Validation through qPCR demonstrates that Formononetin suppresses IgE-mediated mast cell activation by upregulating TP53 gene expression and downregulating the expression of STAT3 and CCND1, ultimately reducing the severity of food allergies (54). The gene discussed is STAT3; the disease is food allergy.